Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma

Sangyeop Hyun; Youngmin Han; Jae Yun Moon; Young-Ah Suh; Won-Gun Yun; Wooil Kwon; Jong-Eun Lee; Daeun Kim; Ja-Lok Ku; Jin-Young Jang; Daechan Park

doi:10.1002/cac2.12585

Cancer Communications ›› 2024, Vol. 44 ›› Issue (08) : 921 -925. DOI: 10.1002/cac2.12585

LETTER TO THE JOURNAL

Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma

Author information +

History +

PDF

Cite this article

Download citation ▾

Sangyeop Hyun, Youngmin Han, Jae Yun Moon, Young-Ah Suh, Won-Gun Yun, Wooil Kwon, Jong-Eun Lee, Daeun Kim, Ja-Lok Ku, Jin-Young Jang, Daechan Park. Defining and tracing subtypes of patient-derived xenograft models in pancreatic ductal adenocarcinoma. Cancer Communications, 2024, 44(08): 921-925 DOI:10.1002/cac2.12585

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014; 4(9): 998–1013.

[2]	Shi J, Li Y, Jia R, Fan X. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance. Int J Cancer. 2020; 146(8): 2078–2088.

[3]	Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C, et al. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiation Oncology. 2019; 14(1): 141.

[4]	Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SG, Hoadley KA, et al. Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015; 47(10): 1168–1178.

[5]	Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016; 531(7592): 47–52.

[6]	Chan-Seng-Yue M, Kim JC, Wilson GW, Ng K, Figueroa EF, O’Kane GM, et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat Genet. 2020; 52(2): 231–240.

[7]	Peng J, Sun B-F, Chen C-Y. Zhou J-Y, Chen Y-S. Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Research. 2019; 29(9): 725–738.

[8]	Gendoo DMA, Denroche RE, Zhang A, Radulovich N, Jang GH, Lemire M, et al. Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer. PLoS Comput Biol. 2019; 15(1): e1006596.

[9]	Romero-Calvo I, Weber CR, Ray M, Brown M, Kirby K, Nandi RK, et al. Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors. Mol Cancer Res. 2019; 17(1): 70–83.

[10]	Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, et al. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features. Gastroenterology. 2018; 155(6): 1999–2013.e3.